| Kumar Venkatachalam, MD | |
|
8895 Broadway, Merrillville, IN 46410-7037 | |
| (219) 738-2081 | |
| (219) 736-4658 |
| Full Name | Kumar Venkatachalam |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 33 Years |
| Location | 8895 Broadway, Merrillville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154325421 | NPI | - | NPPES |
| 110168975 | Other | IN | RAILROAD MEDICARE |
| 9115389 | Other | IL | ANTHEM BC/BS |
| 200180870A | Medicaid | IN | |
| 000000085025 | Other | IN | ANTHEM BC/BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 01048257A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary Medical Center Inc | Hobart, IN | Hospital |
| Methodist Hospitals Inc | Gary, IN | Hospital |
| Community Hospital | Munster, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Care Network Inc | 3678737012 | 360 |
News Archive
Clean water is a matter of survival for humans, particularly when it is used for drinking, cooking and for food manufacture. Therefore, the EU member countries have in several guidelines undertaken to guarantee their citizens sustainable clean drinking water.
As the first program of its kind in the United States, an advanced pain management fellowship prepares Certified Registered Nurse Anesthetists (CRNAs) with the pain management skills necessary to meet the needs of Americans with chronic pain, according to the American Association of Nurse Anesthetists.
Researchers at the Translational Genomics Research Institute (TGen) today announced the discovery of previously unrecognized alterations in a gene called FGFR2 in a subset of endometrial cancers, the most common gynecologic cancer in the United States.
Research institutions at 27 sites in the U.S. and Canada have been selected to participate in the Cancer Immunotherapy Trials Network, a new initiative in immunotherapy funded by the National Cancer Institute and headquartered at Fred Hutchinson Cancer Research Center.
Bristol-Myers Squibb Company today reported results for the fourth quarter and full year of 2013. The fourth quarter was highlighted by the company's announcement to sell its diabetes business as part of the continued evolution of its successful BioPharma strategy to a specialty care model. The company achieved important regulatory milestones in the quarter for Eliquis in the U.S., daclatasvir/asunaprevir in Japan, daclatasvir in Europe and Farxiga in the U.S. In addition, the company provided financial guidance for 2014.
› Verified 8 days ago
| Entity Name | Internal Medicine Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487685178 PECOS PAC ID: 9133191604 Enrollment ID: O20040806000539 |
News Archive
Clean water is a matter of survival for humans, particularly when it is used for drinking, cooking and for food manufacture. Therefore, the EU member countries have in several guidelines undertaken to guarantee their citizens sustainable clean drinking water.
As the first program of its kind in the United States, an advanced pain management fellowship prepares Certified Registered Nurse Anesthetists (CRNAs) with the pain management skills necessary to meet the needs of Americans with chronic pain, according to the American Association of Nurse Anesthetists.
Researchers at the Translational Genomics Research Institute (TGen) today announced the discovery of previously unrecognized alterations in a gene called FGFR2 in a subset of endometrial cancers, the most common gynecologic cancer in the United States.
Research institutions at 27 sites in the U.S. and Canada have been selected to participate in the Cancer Immunotherapy Trials Network, a new initiative in immunotherapy funded by the National Cancer Institute and headquartered at Fred Hutchinson Cancer Research Center.
Bristol-Myers Squibb Company today reported results for the fourth quarter and full year of 2013. The fourth quarter was highlighted by the company's announcement to sell its diabetes business as part of the continued evolution of its successful BioPharma strategy to a specialty care model. The company achieved important regulatory milestones in the quarter for Eliquis in the U.S., daclatasvir/asunaprevir in Japan, daclatasvir in Europe and Farxiga in the U.S. In addition, the company provided financial guidance for 2014.
› Verified 8 days ago
| Entity Name | Community Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457610487 PECOS PAC ID: 3678737012 Enrollment ID: O20120614000331 |
News Archive
Clean water is a matter of survival for humans, particularly when it is used for drinking, cooking and for food manufacture. Therefore, the EU member countries have in several guidelines undertaken to guarantee their citizens sustainable clean drinking water.
As the first program of its kind in the United States, an advanced pain management fellowship prepares Certified Registered Nurse Anesthetists (CRNAs) with the pain management skills necessary to meet the needs of Americans with chronic pain, according to the American Association of Nurse Anesthetists.
Researchers at the Translational Genomics Research Institute (TGen) today announced the discovery of previously unrecognized alterations in a gene called FGFR2 in a subset of endometrial cancers, the most common gynecologic cancer in the United States.
Research institutions at 27 sites in the U.S. and Canada have been selected to participate in the Cancer Immunotherapy Trials Network, a new initiative in immunotherapy funded by the National Cancer Institute and headquartered at Fred Hutchinson Cancer Research Center.
Bristol-Myers Squibb Company today reported results for the fourth quarter and full year of 2013. The fourth quarter was highlighted by the company's announcement to sell its diabetes business as part of the continued evolution of its successful BioPharma strategy to a specialty care model. The company achieved important regulatory milestones in the quarter for Eliquis in the U.S., daclatasvir/asunaprevir in Japan, daclatasvir in Europe and Farxiga in the U.S. In addition, the company provided financial guidance for 2014.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kumar Venkatachalam, MD 8558 Broadway, Merrillville, IN 46410-7032 Ph: (219) 392-7084 | Kumar Venkatachalam, MD 8895 Broadway, Merrillville, IN 46410-7037 Ph: (219) 738-2081 |
News Archive
Clean water is a matter of survival for humans, particularly when it is used for drinking, cooking and for food manufacture. Therefore, the EU member countries have in several guidelines undertaken to guarantee their citizens sustainable clean drinking water.
As the first program of its kind in the United States, an advanced pain management fellowship prepares Certified Registered Nurse Anesthetists (CRNAs) with the pain management skills necessary to meet the needs of Americans with chronic pain, according to the American Association of Nurse Anesthetists.
Researchers at the Translational Genomics Research Institute (TGen) today announced the discovery of previously unrecognized alterations in a gene called FGFR2 in a subset of endometrial cancers, the most common gynecologic cancer in the United States.
Research institutions at 27 sites in the U.S. and Canada have been selected to participate in the Cancer Immunotherapy Trials Network, a new initiative in immunotherapy funded by the National Cancer Institute and headquartered at Fred Hutchinson Cancer Research Center.
Bristol-Myers Squibb Company today reported results for the fourth quarter and full year of 2013. The fourth quarter was highlighted by the company's announcement to sell its diabetes business as part of the continued evolution of its successful BioPharma strategy to a specialty care model. The company achieved important regulatory milestones in the quarter for Eliquis in the U.S., daclatasvir/asunaprevir in Japan, daclatasvir in Europe and Farxiga in the U.S. In addition, the company provided financial guidance for 2014.
› Verified 8 days ago
Dr. Mihas Mamu Kodenchery, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5800 Broadway, Suite A-j, Merrillville, IN 46410 Phone: 219-884-9185 | |
Omar Al Dhaybi, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 90 W 86th Ave, Merrillville, IN 46410 Phone: 219-791-1555 | |
Virginia Tan Tabib, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 8127 Merrillville Rd, Merrillville, IN 46410 Phone: 219-769-4855 Fax: 219-757-5629 | |
Dr. Mohammed Asgar, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 5490 Broadway Ste 106, Merrillville, IN 46410 Phone: 219-939-7130 Fax: 219-951-0883 | |
Gaurav Agarwal, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6061 Broadway, Merrillville, IN 46410 Phone: 219-884-2640 Fax: 219-884-2810 | |
Larry R Brazley, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 255 E 90th Dr, W1, Merrillville, IN 46410 Phone: 219-791-0248 Fax: 219-791-0251 | |
Stephanie D Marshall, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8684 Connecticut St Ste A, Merrillville, IN 46410 Phone: 192-472-8990 Fax: 219-472-0270 |